Metabolism of Arachidonic Acid to Epoxyeicosatrienoic Acids. Hydroxyeicosatetraenoic Acids, and Prostaglandins in Cultured Rat Hippocampal Astrocytes
- 1 July 1993
- journal article
- Published by Wiley in Journal of Neurochemistry
- Vol. 61 (1) , 150-159
- https://doi.org/10.1111/j.1471-4159.1993.tb03550.x
Abstract
We have recently shown that brain slices are capable of metabolizing arachidonic acid by the epoxygenase pathway. The purpose of this study was to begin to determine the ability of individual brain cell types to form epoxygenase metabolites. We have examined the astrocyte epoxygenase pathway and have also confirmed metabolism by the cyclooxygenase and lipoxygenase enzyme systems. Cultured rat hippocampal astrocyte homogenate, when incubated with radiolabeled [3H]arachidonic acid, formed products that eluted in four major groups designated as R17-30, R42-50, R51-82, and R83-90 based on their retention times in reverse-phase HPLC. These fractions were further segregated into as many as 13 peaks by normal-phase HPLC and a second reverse-phase HPLC system. The principal components in each peak were structurally characterized by gas chromatography/electron impact-mass spectrometry. Based on HPLC retention times and gas chromatography/electron impact-mass spectrometry analysis, the more polar fractions (R17-30) contained prostaglandin D2 as the major cyclooxygenase product. Minor products included 6-keto prostaglandin F1 alpha, prostaglandin E2, prostaglandin F2 alpha, and thromboxane B2. Fractions R42-50, R51-82, and R83-90 contained epoxygenase and lipoxygenase-like products. The major metabolite in fractions R83-90 was 5,6-epoxyeicosatrienoic acid (EET). Fractions R51-82 contained 14,15- and 8,9-EETs, 12- and 5-hydroxyeicosatetraenoic acids, and 8,9- and 5,6-dihydroxyeicosatrienoic acids (DHETs). In fractions R42-50, 14,15-DHET was the major product. When radiolabeled [3H]14,15-EET was incubated with astrocyte homogenate, it was rapidly metabolized to [3H]14,15-DHET. The metabolism was inhibited by submicromolar concentration of 4-phenylchalcone oxide, a potent inhibitor of epoxide hydrolase activity. Formation of other polar metabolites such as triols or epoxy alcohols from 14,15-DHET was not observed. In conclusion, astrocytes readily metabolize arachidonic acid to 14,15-EET, 5,6-EET, and their vicinal-diols. Previous studies suggest these products may affect neuronal function and cerebral blood flow.Keywords
This publication has 33 references indexed in Scilit:
- Brain Synthesis and Cerebrovascular Action of Epoxygenase Metabolites of Arachidonic AcidJournal of Neurochemistry, 1992
- 14,15-Epoxyeicosatrienoic acid inhibits platelet aggregation in mouse cerebral arterioles.Stroke, 1991
- Lipoxygenase products of polyunsaturated fatty acid metabolism in the central nervous system: Biosynthesis and putative functionsPharmacological Research, 1990
- Lipoxygenase metabolites of arachidonic acid as second messengers for presynaptic inhibition of Aplysia sensory cellsNature, 1987
- Absolute configuration of the hydroxyeicosatetraenoic acids (HETEs) formed during catalytic oxygenation of arachidonic acid by microsomal cytochrome P-450Biochemical and Biophysical Research Communications, 1986
- 5,6-epoxyeicosatrienoic acid mobilizes Ca2+ in anterior pituitary cellsBiochemical and Biophysical Research Communications, 1986
- Epoxygenation of arachidonic acid by rat anterior pituitary microsomal fractionsFEBS Letters, 1984
- Eicosanoids: Prostaglandins, Thromboxanes, Leukotrienes, and Other Derivatives of Carbon‐20 Unsaturated Fatty AcidsJournal of Neurochemistry, 1982
- Transient Formation of Superoxide Radicals in Polyunsaturated Fatty Acid‐Induced Brain SwellingJournal of Neurochemistry, 1980
- Prostaglandin Profiles in Tissue and Blood Vessels from Human BrainJournal of Neurochemistry, 1980